Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reuters initiated an Outperform rating on 2/21/09.
Reply New Message
Back To Forum List View

Reuters initiated an Outperform rating on 2/21/09.

posted on Feb 23, 2009 07:50AM

This appears to be the same rating as their previous one, with 3 of 4 components rated "Outperform", and the Overall Rating being "Outperform".



Not surprisingly, one component (Technical Factors) continues to be rated "Neutral".

"This rating is based on analyses of share price movements over a variety of time periods."

13 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply